Novel 660 300 mg (Trimethobenzamide hydrochloride 300 mg)
Pill imprint Novel 660 300 mg has been identified as Trimethobenzamide hydrochloride 300 mg.
Trimethobenzamide is used in the treatment of nausea/vomiting and belongs to the drug class anticholinergic antiemetics. FDA has not classified the drug for risk during pregnancy. Trimethobenzamide 300 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- Novel 660 300 mg
- Strength:
- 300 mg
- Color:
- Purple
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Anticholinergic antiemetics
- Pregnancy Category:
- N - Not classified
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Gavis Pharmaceuticals
- National Drug Code (NDC):
- 43386-0660
- Inactive Ingredients:
- lactose monohydrate
magnesium stearate
corn starch
D&C Red No. 28
gelatin
FD&C Blue No. 1
FD&C Red No. 40
titanium dioxide
soya lecithin
water
shellac
ethylene glycol monoethyl ether
More about trimethobenzamide
Consumer resources
- Trimethobenzamide
- Trimethobenzamide solution
- Trimethobenzamide (Advanced Reading)
- Trimethobenzamide Intramuscular (Advanced Reading)
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
